Trials / Recruiting
RecruitingNCT06255990
Clinical and Histological Study of a Novel Dermal Substitute
Clinical and Histological Study of a Novel Dermal Substitute, NovoSorb® BTM, Used in the Treatment of Full-thickness Skin Defects
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 42 (estimated)
- Sponsor
- University Children's Hospital, Zurich · Academic / Other
- Sex
- All
- Age
- 1 Year – 75 Years
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to compare a novel dermal substitute to a the current standard procedure in the treatment of full thickness skin defects. The main questions aim to answer are: • Is the skin elasticity treated with the novel dermal substitute better than the skin elasticity treated with the current standard procedure Participants skin elasticity will be measured by Cutometer® MPA-580 assessment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Standard of care | Standard of care |
Timeline
- Start date
- 2024-01-15
- Primary completion
- 2026-06-01
- Completion
- 2027-06-01
- First posted
- 2024-02-13
- Last updated
- 2026-04-03
Locations
4 sites across 1 country: Switzerland
Source: ClinicalTrials.gov record NCT06255990. Inclusion in this directory is not an endorsement.